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compared with DT.
CONCLUSIONS The degree of coronary artery lesions appears to have
some correlation with ID, IT, DT and IT/DT. High doses of insulin or
high ratio IT/DT may aggravate coronary artery damage.GW26-e2122
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OBJECTIVES To investigate the relationship between hemoglobin A1c
(HbA1c) and left atrial thrombus or left atrial spontaneous echo
contrast (LATH/SEC) in non-valvular atrial ﬁbrillation (NVAF)
patients.
METHODS We enrolled 1158 patients with NVAF who underwent
transesophageal echocardiography (TEE) prior to radiofrequency
catheter ablation, left atrial appendage closure or electric cardiover-
sion at Guangdong Cardiovascular Institute. Data on clinical baseline
characteristic of all the patients were collected from electronic med-
ical records and analyzed.
RESULTS There were 87 NVAF patients with LATH/SEC. The mean
HbA1c was signiﬁcantly higher in NVAF patients with LATH/SEC
(6.130.41% vs. 5.880.45%, P<0.001). Receiver operating charac-
teristic (ROC) curve was presented by HbA1c, which indicated area
under curve was 0.706 (95% Conﬁdence Interval: 0.679-0.732,
P<0.001) and the best HbA1c cut-point was 6.1%. In multivariate lo-
gistic regression analysis, after adjustment for persistent/paroxysmal
AF, age, heart failure, previous stroke, gender and vascular disease,
HbA1c6.1% (Odds Ratio: 2.207, 95%Conﬁdence Interval: 1.306-3.731,
P¼0.003) and diabetes mellitus (Odds Ratio: 1.766, 95%Conﬁdence
Interval: 1.002-3.113, P¼0.049) were independent risk factors for
LATH/SEC.
CONCLUSIONS The mean HbA1c was signiﬁcantly higher in NVAF
patients with LATH/SEC. HbA1c6.1% was an independent risk factor
for LATH/SEC in patients with NVAF. Compared with diabetes melli-
tus, HbA1c6.1% might offer more favorable predictive value on
LATH/SEC.DIABETES
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OBJECTIVES Glycometabolic disturbances have been associated
with increased mortality in patients with acute coronary syndrome
(ACS). However, the predictive value of glycemic variability (GV)
for short-term adverse outcome in diabetic patients after percuta-
neous coronary intervention (PCI) is not clear. The aim of this study
is to investigate the prognostic value of in-hospital GV and hemo-
globin A1c (HbA1c) for 3 months major adverse cardiac events
(MACE) in diabetic patients with unstable angina (UA) undergoing
PCI.
METHODS We studied 459 diabetic patients with UA, whose clinical
data including the global registry of acute coronary events (GRACE)
risk score, GV and HbA1c were collected before elective percuta-
neous coronary intervention (PCI). The GV accessed by mean
amplitude of glycemic excursions (MAGE) in patients were
measured by a continuous glucose monitoring system (CGMS) for72 hours. The MAGE was calculated by measuring the arithmetic
mean of the differences between consecutive peaks and nadirs,
provided that the differences are greater than one standard devia-
tion (SD) of the mean glucose value. Patients were categorized ac-
cording to MAGE level (<3.9 and 3.9 mmol/L), based on reference
values for continuous glucose monitoring in Chinese subjects, and
according to HbA1c level (<6.5% and 6.5%). The MACE of patients
was documented during 3 months follow-up. During follow-up
period, incidences of MACE were registered, including new-onset
myocardial infarction, recurrent angina, repeat target vessel revas-
cularization (TVR) after initial revascularization and cardiac death.
The relationship of MAGE and incidence of MACE in diabetic pa-
tients with UA was analyzed.
RESULTS In all participants, a higher MAGE level or a higher HbA1c
level was associated with the higher GRACE score (r¼0.191, r¼0.165,
all p<0.001). The rate of short-term MACE in high MAGE group was
higher than in low MAGE group (12.4% vs. 4.8%, p¼0.005), and it is
similar between high HbA1c group and low HbA1c group (10.0% vs.
5.8%, p ¼ 0.112). Patients with a higher MAGE level had a signiﬁ-
cantly higher cardiac mortality during 3 months follow-up (1.8% vs.
0%, p ¼ 0.049). The rates of cardiac mortality, repeat infarction,
recurrent angina and TVR in high HbA1c group were similar
compared with low HbA1c group (all p > 0.05). Kaplan-Meier sur-
vival curve analysis showed the incidence of MACE was signiﬁ-
cantly higher in the high MAGE level group (log-rank test, p ¼
0.003). There is a trend toward lower event-free survival rate in
high HbA1c level patients, but the difference is not signiﬁcant (log-
rank test, p ¼ 0.099). In multivariable analysis, high MAGE level
(HR 2.994, 95% CI 1.368-6.579, p¼0.006) was signiﬁcantly associ-
ated with incidence of short-term MACE even after adjusting for
GRACE risk score, but HbA1c (HR 1.592, 95% CI 0.708-3.584,
p¼0.261) was not.
CONCLUSIONS The in-hospital glycemic variability may be a power-
ful predictor of increased short-term MACE and mortality in diabetic
patients with UA following PCI.GW26-e2477
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OBJECTIVES Women with gestational diabetes mellitus (GDM) have
high rates of pregnancy complications. The aim of this study was to
estimate the impact of GDM on pregnant, obstetric and neonatal
outcomes, and to evaluate whether the risk of serious perinatal out-
comes has changed.
METHODS A retrospective double cohort study (3695 participants in
2001; 7428 in 2010) was performed among women who gave birth in
Shanghai First Maternity and Infant Hospital and Shanghai Tenth
People’s Hospital between Jan 1th to Dec 31th in 2001 and 2010. Cox
regression model was conducted to explore the relationship between
GDM and adverse perinatal outcomes.
RESULTS GDM pregnant women had lower values of both body
mass index (23.393.26kg/m2) and hemoglobin (105.6013.48g/L) in
2010 than those (25.104.00kg/m2, 119.2032.89g/L) in 2001 during
their ﬁrst prenatal visit, with an earlier gestational week of ﬁrst
prenatal visit (16.824.62w). Weight gains of GDM women were
controlled in normal range, with the timepoint of diagnose to GDM
being earlier in 2010 than 2001. As shown in Cox regression models,
after adjusted for maternal age, parity, history of spontaneous
abortion, history of ectopic pregnancy, unknown stillbirth and dead
fetal history and family history of diabetes, GDM increased the risk
of adverse outcomes that included macrosomia, hydramnios, Large
for gestational age (LGA), hypertensive disorders complicating
pregnancy(HDP) and cesarean delivery in the model of 2001. The
risk ratio (RR) and 95% conﬁdence interval (CI) were 5.82(3.33-
10.16), 4.48(1.24-16.23), 2.47(1.75-3.48), 2.32(1.01-5.33), 2.15(1.73-
2.68), respectively. Adding moderator variable (body mass index,
